Inclusion Criteria:  Age ≥ 18 years Body Mass index ≥ 27 kg/m2 Albuminuria ≥ 30 mg/g and ≤ 3500 mg/g eGFR ≥ 25 ml/min/1.73m2 Stable renal function prior to entry into the study defined as no more than 30% eGFR change in 3 months prior to enrolment Signed Informed Consent  Exclusion Criteria:  Diagnosis with type 1 or type 2 Diabetes Hba1c ≥ 6.5% at screening Cardiovascular disease event in 3 months prior to enrollment Treatment with GLP-1 RA < 4 weeks prior to screening Uncontrolled thyroid disease TSH>6.0 mIU/L or <0.4 mIU/L at screening Acute pancreatitis < 180 days prior to screening History or presence of chronic pancreatitis Females of child-bearing potential who are pregnant, breast-feeding or have intention of becoming pregnant or are not using adequate contraceptive measures